Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US

by The Welthi Bureau | 28 JULY 2018

lupin launches generic desoximetasone topical spray 0.25 per cent in the us
 Image used for representational purpose only

Mumbai, Baltimore, 27th July 2018: Pharma major Lupin announced the launch of its Desoximetasone Topical Spray, 0.25%, having received an approval from the United States Food and Drug Administration (FDA) earlier.


Lupin’s Desoximetasone Topical Spray, 0.25% is the generic equivalent of Taro Pharmaceuticals U.S.A Inc.’s Topicort® Topical Spray, 0.25%. It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.


Desoximetasone Topical Spray, 0.25% had annual sales of approximately USD 18.7 million in the US (IQVIA MAT May 2018).

 Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person. Read more